ChitogenX Inc. (CHGX.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.02 CAD | 83.62% |
| 2022 | -0.13 CAD | 23.53% |
| 2021 | -0.17 CAD | -6.25% |
| 2020 | -0.16 CAD | -45.45% |
| 2019 | -0.11 CAD | -13.52% |
| 2018 | -0.10 CAD | 19.25% |
| 2017 | -0.12 CAD | -54.04% |
| 2016 | -0.08 CAD | -21.34% |
| 2015 | -0.06 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.00 CAD | 65.45% |
| 2024 Q2 | -0.00 CAD | -110.53% |
| 2023 Q3 | -0.01 CAD | -84.91% |
| 2023 Q1 | 0.00 CAD | 104.49% |
| 2023 Q2 | -0.01 CAD | -378.95% |
| 2023 Q4 | -0.01 CAD | 43.88% |
| 2023 FY | - CAD | 83.62% |
| 2022 Q2 | -0.03 CAD | -24.19% |
| 2022 FY | - CAD | 23.53% |
| 2022 Q4 | -0.04 CAD | -16.21% |
| 2022 Q3 | -0.04 CAD | -36.33% |
| 2022 Q1 | -0.02 CAD | 11.89% |
| 2021 Q4 | -0.02 CAD | 55.8% |
| 2021 Q1 | -0.04 CAD | 3.26% |
| 2021 Q2 | -0.03 CAD | 27.25% |
| 2021 Q3 | -0.06 CAD | -113.13% |
| 2021 FY | - CAD | -6.25% |
| 2020 Q4 | -0.04 CAD | -40.46% |
| 2020 FY | - CAD | -45.45% |
| 2020 Q3 | -0.03 CAD | -2.75% |
| 2020 Q1 | -0.04 CAD | -122.92% |
| 2020 Q2 | -0.03 CAD | 40.42% |
| 2019 FY | - CAD | -13.52% |
| 2019 Q4 | -0.02 CAD | 30.94% |
| 2019 Q3 | -0.03 CAD | -4.12% |
| 2019 Q2 | -0.03 CAD | -12.18% |
| 2019 Q1 | -0.02 CAD | 14.08% |
| 2018 Q2 | -0.02 CAD | 10.96% |
| 2018 Q1 | -0.02 CAD | 56.55% |
| 2018 Q3 | -0.03 CAD | -61.54% |
| 2018 Q4 | -0.03 CAD | 12.06% |
| 2018 FY | - CAD | 19.25% |
| 2017 FY | - CAD | -54.04% |
| 2017 Q1 | -0.01 CAD | -35.0% |
| 2017 Q2 | -0.02 CAD | -32.59% |
| 2017 Q3 | -0.02 CAD | -25.7% |
| 2017 Q4 | -0.05 CAD | -124.0% |
| 2016 Q2 | -0.02 CAD | -31.75% |
| 2016 FY | - CAD | -21.34% |
| 2016 Q4 | -0.01 CAD | 50.0% |
| 2016 Q1 | -0.02 CAD | 42.55% |
| 2016 Q3 | -0.02 CAD | 19.68% |
| 2015 Q2 | -0.00 CAD | -52.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q4 | -0.03 CAD | -181.2% |
| 2015 Q1 | -0.00 CAD | 0.0% |
| 2015 Q3 | -0.01 CAD | -207.89% |
| Name | Eps | Eps Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -0.45 CAD | 95.267% |
| Asep Medical Holdings Inc | -0.13 CAD | 83.615% |
| BetterLife Pharma Inc. | -0.03 CAD | 19.318% |
| BioVaxys Technology Corp. | -0.06 CAD | 62.827% |
| Rapid Dose Therapeutics Corp. | -0.04 CAD | 48.049% |
| Defence Therapeutics Inc. | -0.30 CAD | 92.9% |
| Entheon Biomedical Corp. | -0.05 CAD | 58.071% |
| Gemina Laboratories Ltd. | -0.07 CAD | 70.417% |
| Glow Lifetech Corp. | -0.03 CAD | 26.042% |
| Lexston Life Sciences Corp. | -0.02 CAD | 7.391% |
| Pharmala Biotech Holdings Inc. | -0.01 CAD | -131.522% |
| Doseology Sciences Inc. | -0.08 CAD | 73.275% |
| MYND Life Sciences Inc. | -0.03 CAD | 33.645% |
| Nova Mentis Life Science Corp. | -0.01 CAD | -156.627% |
| PharmaTher Holdings Ltd. | -0.04 CAD | 39.66% |
| PreveCeutical Medical Inc. | -0.00 CAD | -787.5% |
| Telescope Innovations Corp. | -0.12 CAD | 82.25% |